Abstract: Different cryoprotectants can influence the ability of embryos to successfully survive vitrification and subsequent warming before transfer. Objective: To compare pregnancy rates for embryos ≤500 μm vitrified, without puncture or aspiration of the blastocoele cavity, with one of three commercial human embryo vitrification kits containing the same penetrating cryoprotectants (DMSO and EG) but varying in their non-penetrating cryoprotectants (NPCPAs; sucrose, trehalose, dextran serum supplement [DSS], and hydroxypropyl cellulose [HPC]). Methods: In vivo experiments. Methods: Embryos (n = 108) were vitrified using either a Kitazato (NPCPAs = trehalose, hydroxypropyl cellulose), Vit Kit Freeze (NPCPAs = sucrose, DSS), or Vit Kit Freeze NX (NPCPAs = trehalose, DSS) vitrification kit by exposing each embryo to kit-specific equilibration solution for 15 min, before the vitrification solution for ≤90 sec including loading onto a Cryolock device, which was capped and plunged into LN2. All embryos were warmed in the same media by placing the Cryolock tip into 1 mL of 1.0 M sucrose in a HEPES-based medium (1 min), followed by 0.5 M sucrose (4 min) and then commercial Holding medium (4 min) before transfer to a Day 6 recipient mare. For each kit, embryos were divided by size into three groups (G1 ≤ 300 μm; G2 > 300-400 μm; G3 > 400-500 μm; n = 8-14/group/kit). Results: Pregnancy rates were equivalent for the Kitazato, Vit Kit Freeze, and Vit Kit Freeze NX kits for embryos in G1 (12/14 [85.7%] vs. 8/11 [72.7%] vs. 7/8 [87.5%], respectively, p = 0.63) and for G2 (10/12 [83.3%] vs. 10/11 [90.9%] vs. 9/11 [81.8%], respectively, p = 0.81). For G3 embryos, pregnancy rates were higher for the Kitazato versus either of the other kits (10/14 [71.4%] vs. 3/12 [21.4%] vs. 2/14 [14.3%], respectively, p = 0.003). Conclusions: Limited numbers. Conclusions: Different non-penetrating/extracellular cryoprotectants can influence the success of vitrifying equine embryos 400-500 μm. The combination of trehalose and hydroxypropyl cellulose appears to be beneficial in this respect. Unassigned: Verschiedene Kryoprotektionsmittel können die Fähigkeit der Embryonen beeinflussen, die Vitrifikation und die anschließende Erwärmung vor dem Transfer erfolgreich zu überstehen. Unassigned: Vergleich der Schwangerschaftsraten von Embryonen, die ≤500 μm vitrifiziert wurden, ohne Punktion oder Aspiration der Blastozelenhöhle, mit einem von drei kommerziellen Kits zur Vitrifikation menschlicher Embryonen, die dieselben durchdringenden Kryoprotektoren (DMSO und EG), aber unterschiedliche nicht durchdringende Kryoprotektoren (NP‐CPAs; Saccharose, Trehalose, Dextran Serum Supplement [DSS], Hydroxypropyl Cellulose [HPC]) enthalten. Unassigned: In vivo Studie. Methods: Embryonen (n = 108) wurden entweder mit einem Kitazato (NPCPAs = Trehalose, Hydroxypropylcellulose), Vit Kit Freeze (NPCPAs = Saccharose, DSS) oder Vit Kit Freeze NX (NPCPAs = Trehalose, DSS) vitrifiziert, indem jeder Embryo 15 Minuten lang einer kit‐spezifischen Äquilibrierungslösung ausgesetzt wurde, bevor er für ≤90 Sekunden in eine Cryolock‐Vorrichtung geladen wurde, die verschlossen und in LN2 getaucht wurde. Alle Embryonen wurden in denselben Medien erwärmt, indem die Cryolock‐Spitze in 1 mL 1,0 M Saccharose in einem HEPES‐basierten Medium (1 Minute), gefolgt von 0,5 M Saccharose (4 Minuten) und anschließendem handelsüblichen Holding‐Medium (4 Minuten) vor dem Transfer zu einer Empfängerstute an Tag 6 gelegt wurde. Für jedes Kit wurden die Embryonen nach Größe in drei Gruppen eingeteilt (G1 ≤3 00 μm; G2 > 300–400 μm; G3 > 400–500 μm; n = 8–14/Gruppe/Kit). Unassigned: Die Schwangerschaftsraten waren für die Kits Kitazato, Vit Kit Freeze und Vit Kit Freeze NX für Embryonen in G1 (12/14 [85,7%] vs. 8/11 [72,7%] vs. 7/8 [87,5%], jeweils, p = 0,63) und für G2 (10/12 [83,3%] vs. 10/11 [90,9%] vs. 9/11 [81,8%], jeweils, p = 0,81) gleich. Bei G3‐Embryonen waren die Schwangerschaftsraten bei Kitazato höher als bei den anderen Kits (10/14 [71,4%] vs. 3/12 [21,4%] vs. 2/14 [14,3%], p = 0,003). Unassigned: Begrenzte Anzahl. Unassigned: Verschiedene nichtpenetrierende/extrazelluläre Kryoprotektoren können den Erfolg der Vitrifizierung von 400–500 μm Embryonen beeinflussen. Die Kombination von Trehalose und Hydroxypropylcellulose scheint in dieser Hinsicht von Vorteil zu sein.
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
This study compares the effectiveness of three commercial human embryo vitrification kits in preserving equine embryos for future use. The research found that the kind of non-penetrating compounds in the kit can significantly affect the success of embryo vitrification, particularly for larger embryos.
Objective of the Research
The aim of the study was to compare the rates of successful pregnancies resulting from in vivo equine embryos cryopreserved using three commercial human embryo vitrification kits. Each of these kits contained the same penetrating cryoprotectants (Dimethyl Sulfoxide [DMSO] and Ethylene Glycol [EG]) but varied in their non-penetrating cryoprotectants (NPCPAs; sucrose, trehalose, dextran serum supplement [DSS], and hydroxypropyl cellulose [HPC]).
Research Methods
For the experiment, 108 embryos were vitrified using one of the three kits: Kitazato (trehalose, hydroxypropyl cellulose as NPCPAs), Vit Kit Freeze (sucrose, DSS as NPCPAs), or Vit Kit Freeze NX (trehalose, DSS as NPCPAs).
Each embryo exposed to a kit-specific equilibration solution for 15 minutes, followed by the vitrification solution for less than or equal to 90 seconds, resulting in the loading onto a Cryolock device and plunged into liquid nitrogen (LN2).
All embryos were then warmed using the same method in a specified medium, followed by a transfer to a Day 6 recipient mare.
The embryos were categorized into three groups based on their size to check for variations in success rates due to size.
Results of the Study
It was observed that the pregnancy rates were similar for embryos in group 1 (up to 300 μm in size) and group 2 (size 300-400 μm) for all three kits.
However, for group 3 embryos (size 400-500 μm), the success rates were higher when the Kitazato kit, with trehalose and hydroxypropyl cellulose as NPCPAs, was used.
Conclusions
The outcomes of the study show that the type of non-penetrating/extracellular cryoprotectants significantly influences the success rate of vitrification, particularly for larger equine embryos between 400-500 μm in size.
The combination of trehalose and hydroxypropyl cellulose as NPCPAs was found to be particularly beneficial for this size range of embryos.
Cite This Article
APA
Wilsher S, Ismer A, Grippo A, Hoogewijs M, Bussade P, Kovacsy S.
(2025).
A comparison of the efficacy of three commercial human embryo vitrification kits for cryopreservation of in vivo produced equine embryos.
Equine Vet J.
https://doi.org/10.1111/evj.14539
Sanchez R, Blanco M, Weiss J, Rosati I, Herrera C, Bollwein H. Influence of embryonic size and manipulation on pregnancy rates of mares after transfer of cryopreserved equine embryos.. J Equine Vet Sci 2017;49:54–59.
Kovacsy S, Ismer A, Hoogewijs M, Funes J, Wilsher S. Successful vitrification of equine embryos >300 μm without puncture or aspiration.. Equine Vet J 2024;56:815–822.
Ferris RA, McCue PM, Trundell DA, Morrissey JK, Barfield JP. Vitrification of large equine embryos following manual or micromanipulator‐assisted blastocoele collapse.. J Equine Vet Sci 2016;41:64–65.
Rusczyk R. Introduction to geometry. 2nd ed. San Diego, CA: Aops Inc; 2007.
Parmegiani L, Beilby KH, Arnone A, Bernardi S, Maccarini AM, Nardi E. Testing the efficacy and efficiency of a single ‘universal warming protocol’ for vitrified human embryos: prospective randomized controlled trial and retrospective longitudinal cohort study.. J Assist Reprod Genet 2018;35:1887–1895.
Canosa S, Parmegiani L, Charrier L, Gennerelli G, Garello C, Granella F. Are commercial warming kits interchangeable for vitrified human blastocysts? Further evidence for the adoption of a Universal Warming protocol.. J Assist Reprod Genet 2022;39:67–73.
Coella A, Campos P, Remohi J, Meseguer M, Cobo A. A combination of hydroxypropyl cellulose and trehalose as supplementation for vitrification of human occytes: a retrospective cohort study.. J Assist Reprod Genet 2016;33:413–421.
Swain JE, Smith GD. Cryoprotectants.. In: Chian RC, Quinn P, editors. Fertility cryopreservation. Cambridge: Cambridge University Press; 2010. p. 24–38.
MacKenzie AP. Non‐equilibrium freezing behaviour of aqueous systems.. Philos Trans R Soc Lond B Biol Sci 1977;278:167–189.
Sola‐Penna M, Meyer‐Fernandes JR. Stabilisation against thermal inactivation promoted by sugars on enzyme structure and function: why is trehalose more effective than other sugars?. Arch Biochem Biophys 1998;360:10–14.
Kuleshova LL, MacFarlane DR, Trounson AO, Shaw JM. Sugars exert a major influence on the vitrification properties of ethylene glycol‐based solutions and have low toxicity to embryos and oocytes.. Cryobiology 1999;38:119–130.
Lestari SW, Fitriyah NN, Pangestu M, Pratama G, Margiana R. Comparison of sucrose and trehalose media modification as an update of oocyte vitrification: a study of apoptotic level.. AIP Conf Proc 2018;1933:030017.
Bagis H, Sagirkaya H, Odaman Mercan H, Dinnyès A. Vitrification of pronuclear‐stage mouse embryos on solid surface (SSV) versus in cryotube: comparison of the effect of equilibration time and different sugars in the vitrification solution.. Mol Reprod Dev 2004;67:186–192.
Lagares MA, Castanheira PN, Amaral DCG, Vasconcelos AB, Veado JCC, Arantes RME. Addition of ficoll and disaccharides to vitrification solutions improve in vitro viability of vitrified equine embryos.. Cryo Letters 2009;30:408–413.
Somfai T, Men NT, Noguchi J, Kaneko H, Kashiwazaki N, Kikuchi K. Optimization of cryoprotectant treatment for the vitrification of immature cumulus‐enclosed porcine oocytes: comparison of sugars, combinations of permeating cryoprotectants and equilibration regimens.. J Reprod Dev 2015;61:571–579.
Inoue F. Hydroxypropyl cellulose as a macromolecular supplement for cryopreservation by vitrification of bovine oocytes and blastocysts and human oocytes.. Fertil Steril 2013;96:212–213.
Kuwayama M. Efficiency of non‐protein solutions using hydroxypropyl cellulose on survival of bovine and human oocytes and embryos after vitrification.. Fertil Steril 2013;100:S174.
Mori C, Yabuuchi A, Ezoe K, Murata N, Takayama Y, Okimura T. Hydroxypropyl cellulose as an option for supplementation of cryoprotectant solutions for embryo vitrification in human assisted reproductive technologies.. Reprod Biomed Online 2015;30:613–621.
Gallardo M, Hebles M, Migueles B, Dorado M, Aguilera L, González M. Hydroxypropyl cellulose supplementation in vitrification solutions: a prospective study with donor oocytes.. J Assist Reprod Genet 2017;34:417–422.
Park MJ, Lee SE, Yoon JW, Park HJ, Kim SH, Oh SH. Effect of supplementation of cryoprotectant solution with hydroxypropyl cellulose for vitrification of bovine oocytes.. Animals (Basel) 2022;12:2636.
Jung SE, Moon Y, Lim M, Jeong H, Seo H. Glucose-Enhanced Cryopreservation of hCAR-T Cells: Improved Recovery and Reduced Apoptosis. Biomol Ther (Seoul) 2025 Nov 1;33(6):963-974.